Skip to content

银杏生物工程

US · DNA #3438 按市值排名
10.27 -1.49 -12.67%
实时 - 追踪5344个代码 - 心跳于82秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期(2026/Q3)披露持股的机构数量减少了3家。
  • 机构持股总比例下降了7.0个百分点。

机构持股

机构持股比例
59.06% -6.99pp
机构数量
216 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund35.57%
Individual/Insider14.96%
Hedge Fund13.85%
Family Office/Trust4.95%
Public Company2.29%
VC/PE Fund1.13%
Private Company0.79%
Insurance Company0.31%
Government Pension Fund0.17%
Other25.98%

主要股东 截至 2026-06-30

BlackRock 6.36% · 4.28M 股
Viking Global Investors LP 5.31% · 3.58M 股
Cascade Investment, L.L.C. 4.93% · 3.32M 股
Erste Asset Management GmbH 3.77% · 2.54M 股
Reshma Shetty 3.69% · 2.49M 股
Vanguard Capital Management, LLC 3.56% · 2.40M 股
Baillie Gifford 3.55% · 2.39M 股
Austin Che 3.54% · 2.39M 股
Bartholomew Canton 3.54% · 2.38M 股
Jason Kelly 3.50% · 2.36M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 18次买入 · 32次卖出

姓名职务持股比例
Reshma Shetty Founder, President, COO & Director 3.69%
Austin Che Founder, Head of Strategy & Treasurer 3.54%
Bartholomew Canton Founder, CTO & Secretary 3.54%
Jason Kelly Chief Executive Officer 3.50%
Harry Sloan Independent Director 0.40%
Shyam Sankar Independent Chairperson 0.11%
Steven Coen Chief Accounting Officer 0.08%
Sriram Kosuri Director 0.04%
Christian O. Henry Independent Director 0.03%
Ross Fubini Independent Director 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-04 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -2,403 $15.00
2026-09-16 Austin Che Founder, Head of Strategy & Treasurer Intent to Sell (Form 144) -2,200 $7.29
2026-09-14 Christian O. Henry Independent Director Open Market Disposition -5,000 $7.08
2026-08-23 Steven Coen Chief Accounting Officer Derivative Exercise and Sale -330 $6.98
2026-08-23 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -330 $6.98
2026-08-20 Steven Coen Chief Accounting Officer Derivative Exercise and Retained +413 --
2026-08-16 Austin Che Founder, Head of Strategy & Treasurer Intent to Sell (Form 144) -2,200 $6.66
2026-07-27 Jason Kelly Chief Executive Officer Other Derivative Acquisition +383,725 --
2026-07-27 Reshma Shetty Founder, President, COO & Director Other Derivative Acquisition +319,332 --
2026-07-27 Bartholomew Canton Founder, CTO & Secretary Other Derivative Acquisition +319,332 --
2026-07-16 Steven Coen Chief Accounting Officer Derivative Exercise and Sale -752 $7.90
2026-07-16 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -752 $7.90
2026-07-15 Steven Coen Chief Accounting Officer Derivative Exercise and Retained +734 --
2026-06-10 Harry Sloan Independent Director Other Derivative Acquisition +25,000 --
2026-06-10 Christian O. Henry Independent Director Other Derivative Acquisition +25,000 --
2026-06-10 Ross Fubini Independent Director Other Derivative Acquisition +25,000 --
2026-06-10 Sriram Kosuri Director Other Derivative Acquisition +25,000 --
2026-06-09 Austin Che Founder, Head of Strategy & Treasurer Intent to Sell (Form 144) -2,200 $8.06
2026-05-21 Steven Coen Chief Accounting Officer Derivative Exercise and Sale -307 $8.33
2026-05-21 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -307 $8.33

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:33 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

银杏生物工程 讨论区 0 条评论

发表评论